跳至主要内容
临床试验/ACTRN12621000258853
ACTRN12621000258853招募中未知

A multi-centre, single arm, prospective, pre-market safety and efficacy evaluation study on automated external defibrillator (CellAED) to terminate arrhythmias in patients (VT or VF) and restore normal sinus rhythm.

RRR Manufacturing Pty Ltd0 个研究点目标入组 25 人开始时间: 2021年3月10日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • INCLUSION CRITERIA:
  • 1. Patients scheduled for a routine cardiac procedure where they
  • are likely to experience episodes of VT/VF
  • 2. Patient is willing and able to provide written Informed Consent
  • by signing and dating the relevant Ethics Committee approved
  • Informed Consent
  • 3. Patient is 18 years of age or older

排除标准

  • EXCLUSION CRITERIA:
  • 1. Patient is considered a member of a protected population
  • (Pregnant, prisoner, mentally incompetent, etc.)
  • 2. Patient is enrolled in a competing/conflicting clinical trial
  • 3. Patient has a condition which would, in the judgement of the
  • investigator, place the patient at undue risk or interfere with
  • the conduct of the study
  • 4. Patient is institutionalised or is a known drug abuser, a known
  • alcoholic or cannot understand the requirements of study
  • participation

研究者

发起方
RRR Manufacturing Pty Ltd

相似试验